Physicians who refer privately insured patients to themselves or members of their own specialty for imaging exams order them more frequently than physicians who send patients to radiologists, according to Massachusetts General Hospital researchers.
Physicians who refer privately insured patients to themselves or members of their own specialty for imaging exams order them more frequently than physicians who send patients to radiologists, according to Massachusetts General Hospital researchers.
Principal investigator Dr. G. Scott Gazelle, director of MGH's Institute of Technology Assessment, and colleagues analyzed more than 526 million claims filed between 1999 and 2003. Investigators sought out the provider of the professional interpretation and organized data according to six conditions: cardiopulmonary disease, cardiovascular disease, extremity fracture, knee pain, intra-abdominal malignancy, and stroke. They then categorized each physician's proclivity to self-refer studies or refer them to radiologists (Radiology 2007 Nov;245[2]: 517-522).
Researchers found that self-referring physicians use imaging about twice as often as those who send their patients to radiologists. They also found that patient age and comorbidity do not explain the increased frequency for self-referred imaging.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.